Showing results (1531-1540 of 3,015) with videos related to

Sort By:
Pageof 302
Clinical Kidney Journal|February 20, 2025
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapyArjunmohan Mohan, Elena-Bianca Barbir, Loren Herrera Hernandez, et al.
Clinical Kidney Journal|February 19, 2025
Factors influencing early response of IgA nephropathy following targeted-release budesonide (TRB) treatment: preliminary results from a multicenter studyChristodoulos Keskinis, Eleni Moysidou, Eleni Kapsia, et al.
Clinical Kidney Journal|November 7, 2024
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemicMingyue Xu, Ruiying Chen, Yifeng Wang, et al.
Clinical Kidney Journal|November 6, 2025
Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL studyTilla C Folttmann, Antje M Haas, Nicholas C Chesnaye, et al.
Clinical Kidney Journal|November 6, 2025
Cardiac complications in autosomal dominant polycystic kidney disease: links to genotype and CKD severityGiulia Condello, Pierluigi Fulignati, Viola D'Ambrosio, et al.
Clinical Kidney Journal|October 13, 2025
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohortZhong Hong Liew, Miao Li Chee, Riswana Banu, et al.
Clinical Kidney Journal|September 25, 2025
Empagliflozin and fluid balance: results from the SiRENA projectSteffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, et al.
Clinical Kidney Journal|September 24, 2025
Size-selective glomerular filtration as a hallmark of premature kidney ageing in nondiabetic individualsAgne Laucyte-Cibulskiene, Christopher Nilsson, Amra Jujic, et al.
Clinical Kidney Journal|September 24, 2025
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidenceAghiles Hamroun, Amadou Tidiane Niang, Florent Occelli, et al.
Clinical Kidney Journal|September 22, 2025
Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction ToolXue Shen, Pei Chen, Lijun Liu, et al.
Pageof 302